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Factors related to outcome of neuroischemic/
ischemic foot ulcer in diabetic patients
Jan Apelqvist, MD, PhD,a Targ Elgzyri, MD,a Jan Larsson, MD, PhD,b Magnus Löndahl, MD, PhD,a
Per Nyberg, MD, PhD,c and Johan Thörne, MD, PhD,d Malmö, Lund, and Helsingborg, Sweden
Objectives: Peripheral vascular disease (PVD) is an important limiting factor for healing in neuroischemic or ischemic
diabetic foot ulcer. The purpose of this study was to identify factors related to healing in patients with diabetes with foot
ulcers and severe PVD.
Methods: Patients with diabetes with a foot ulcer, consecutively presenting at a multidisciplinary foot center with a systolic
toe pressure <45 mm Hg or an ankle pressure <80 mm Hg were prospectively included, followed according to a preset
program, and with the exception of specified exclusions, subjected to angiography offered vascular intervention when
applicable. All patients had continuous follow-up until healing or death irrespective of the type of vascular intervention.
Results: One thousand one hundred fifty-one patients were included. Eighty-two percent had a toe pressure<45 mm Hg
and 49% had an ankle pressure<80 mm Hg. Eight hundred one patients (70%) underwent an angiography. Out of these,
63% had vascular intervention, either percutaneous transluminal angioplasty (PTA; 39%) or reconstructive surgery (24%).
Nine percent of the patients had one or more complications after angiography. PTA was multisegmental in 46% and to
the crural arteries in 46%. Reconstructive surgery was distal in 51%. Age (P < .001), renal function impairment (P 
.005), congestive heart failure (P  .01), number and type of ulcer (P < .001), and severity of PVD (P  .003) affected
the outcome of ulcers. PTA and reconstructive vascular surgery increased the probability of healing without amputation
(odds ratio [OR], 1.77 and 2.05, respectively).
Conclusion: Probability of ulcer healing is strongly related to comorbidity, extent of tissue involvement, and severity of
PVD in patients with diabetes with severe PVD. (J Vasc Surg 2011;53:1582-8.)
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cThe diabetic foot can be defined as infection, ulcer-
ation, and/or destruction of deep tissues associated with
neurological abnormalities and various degrees of periph-
eral vascular disease (PVD) in the lower limb in patients
with diabetes.1 Foot complications in diabetes present a
particularly troubling picture, and it has been claimed that
every 30 seconds a lower limb is amputated due to diabe-
tes.2 The population of patients with diabetes that present
with foot ulceration is heterogeneous. The complexity of
diabetic foot necessitates a profound knowledge of under-
lying pathophysiology and a multifactorial approach.1
However, there are a limited number of studies presenting
data on current outcomes and determinants of outcome in
individuals with diabetic foot ulcers, especially regarding
ischemic or neuroischemic foot ulcers.1,3,4 Most studies in
ischemic conditions are focused on limb salvage after a
specific intervention.5,6
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1582PVD is considered to be the most important limiting
actor for healing of ischemic or neuroischemic diabetic
oot ulcers.1,4,7,8 Noninvasive vascular testing has been
hown to predict probability for healing of diabetic foot
lcers.1,7,9 Few studies evaluate outcome in ischemic or
euroischemic foot ulcers irrespective of vascular interven-
ion. The purpose of this study was to identify factors
elated to healing of ulcers and the possibility for vascular
ntervention in consecutively presenting patients with dia-
etes with foot ulcers and severe PVD treated in a multi-
isciplinary system, both in and out of the hospital until
ealing is achieved or death unhealed.
ETHODS
Study population. Consecutively, presenting patients
ith diabetes and foot ulcer (Wagner grades 1-5, at or
elow the ankle) admitted to a multidisciplinary foot center
n  1151) were prospectively included between years
984 to 2006, treated, and followed up according to a
tandardized protocol until healing or death. The study was
esigned to follow every patient for 5 years after interven-
ion with regard to recurrence ulceration, new ulcers, am-
utation, and death.
Inclusion criteria. Individuals with diabetes mellitus
nd foot ulcer and a systolic toe pressure 45 mm Hg, a
ystolic ankle pressure 80 mm Hg, or in case of nonmea-
urable pressure levels, nonpalpable foot pulses with ulcer
agner grades 4 to 5 or pain at rest. All patients fulfilled
ontaine grade 4.10
Study design. Patients were followed and treated ac-
ording to a preset standardized protocol by a multidisci-
linary team both in and out of the hospital until healing
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Volume 53, Number 6 Apelqvist et al 1583with or without amputation was achieved, or until the
patient died with an unhealed ulcer. All lesions were as-
sessed and documented by the same team. Outpatient
treatment was carried out in collaboration with primary
health care and home nursing services. Physical examina-
tion of the foot was performed at inclusion and regularly
during the study by the multidisciplinary team.
The core team consisted of a diabetologist, an ortho-
pedic surgeon, an orthotist, a podiatrist, and a registered
nurse educated in diabetes. Vascular investigation was car-
ried out according to a prescheduled program by a vascular
surgeon integrated in the team on a regular basis. Specially
trained casting technicians provided continuous service for
total contact casting. A specialist in infectious disease was
available for consultations when required.
All data were recorded on standardized case record forms;
these forms were both computerized and transformed into
files. At study, entry data were collected on previous manage-
ment, referral, patient characteristics, comorbidities, ulcer
characteristics, and laboratory investigations.
Each patient was represented by one lesion below the
ankle. Patients with several concurrent lesions were repre-
sented by the onewith theworst outcome. Patients with three
or more ulcers on the same foot were classified as having
multiple ulcers. The most superficial ulcer included was a full
thickness skin ulcer penetrating into the subcutaneous layer.
A detailed description of definitions, and the medical
and surgical management is available in the Supplementary
Information (online only).
Measurements. Systolic toe and ankle blood pressure
was measured using strain gauge andDoppler techniques at
the vascular laboratory.9 Signs of sensory polyneuropathy
were tested using biothesiometer (BioMedical Instru-
ments, New Burry, Ohio) and defined as present at bio-
thesiometer values of25 V.11 At the time of the design of
the study, vibratory pressure threshold measured by bio-
thesiometer was the most commonly used technique to
establish the presence of sensory polyneuropathy and was
used as routine in our center for screening for neuropathy
in the foot as it predicts subsequent ulceration, although it
does not evaluate all modalities of neuropathy.1,11
Vascular intervention. Angiography was performed
at the discretion of a vascular surgeon according to a
written program that was jointly agreed upon in advance. A
retrograde aortofemoral angiography, routinely visualizing
distal vessels as well as the pedal arch, was performed if
medical condition allowed and if informed consent was
given by the patient. The catheter was placed as far distally
as possible and delayed and magnified lateral foot views
were routinely obtained. The popliteal and crural arteries
were selectively catheterized if possible. Simultaneous per-
cutaneous transluminal angioplasty (PTA) was performed
when possible.
Exclusion criteria for angiography were:
- Medical condition not allowing angiography.
- Extensive gangrene (Wagner grade 5) but not ulcer
location.- Major amputation performed before angiography. aSubjective life expectancy of the patient 6 months.
Signs of ulcer healing before angiography.
Lack of walking capacity before occurrence of ulcer,
restitution not expected.
Informed consent for angioplasty refused.
All patients undergoing angiography with or without
TA were treated according to a program before and after
ntervention regarding hydration and choice of pharmaceu-
ical drugs to avoid renal failure.12 After patients with PTA
ere put on low molecular heparin for a minimum of 3
onths.13 All patients were treated with acetylsalicylic acid
r clopidogrel if no contraindication was present.
In patients where PTA was not possible or not success-
ul, reconstructive surgery was considered and performed at
he discretion of the vascular surgeon, provided their med-
cal condition allowed surgery and informed consent could
e obtained. Distal reconstructive surgery was defined as
ypass to or distal to the truncal tibiofibular artery. Post-
perative care and follow-up were performed in coopera-
ion and supervision by the team according to the program.
Patients not available for angiography or revasculariza-
ion after angiography were considered for treatment with
ow molecular heparin or ketanserin, if feasible, according
o comorbidity.13,14 All patients, irrespective of interven-
ion, were followed by the team according to protocol until
final outcome.
Statistics. Values are given as median and range.
omparisons between groups were made using the Mann-
hitney or 2 test. Statistical significance was defined as a
value  .05. The simultaneous influence of possible risk
actors on a binary outcome (primary healing and amputa-
ion) was investigated bymeans of backward logistic regres-
ion analysis. Statistical analysis was performed using SPSS
ersion 14.0 (SPSS, Chicago, Ill).
ESULTS
Vascular intervention and complications. One thou-
and one hundred fifty-one patients were included in the
tudy. After 5 dropped out, 1146 continued to follow-up
n the study (2 years, 0.5-5). Out of these (age 75 years,
0-92), 61% were males, 69% were treated with insulin,
nd 18% were smokers. Intermittent claudication was
resent in 26% of patients and pain at rest in 52%. Systolic
oe pressure45 mmHg and an ankle pressure80 mm
g were seen in 82% and 49%, respectively (Table I).
agner grade at inclusion did not correlate to ankle-
rachial or toe-brachial pressure indexes (data not
hown).
In 345 patients (30%), no angiography was done
Fig), while 801 patients had an angiography. Fourteen
atients were excluded (dropped out) among those who
id not have an angiography done. Patients who did not
ave an angiography done continued with conservative
reatment at the diabetic foot clinic according to the
rogram.
Angiography vs no angiography. Patients with no
ngiography more often had cerebrovascular disease
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with angiography more often had intermittent claudica-
tion (P  .001), rest pain (P  .001), multiple ulcers
(P  .001), and minor gangrene (P  .01; Table I).
Patients who had PTA or reconstructive vascular surgery
more often had intermittent claudication (P  .01), rest
pain (P  .001), minor gangrene (P  .001), and
multiple ulcers (P  .05), and more often were current
smokers compared with patients who had an angiogra-
phy but no vascular intervention (Table I). In total, a
dropout rate of 5% was seen; 14 patients before and 46
Table I. Clinical characteristics of the subjects
All patients
(n  1146)
No angiography
(n  345)
Angio
(n 
Age (years) 75 (40-92) 77 (46-87) 74 (40
Male gender 61% (700) 59% (203) 62% (49
Duration of diabetes
(years)
15 (0-58) 15 (1-58) 15 (0-
Insulin therapy 69% (786) 62% (213) 71% (56
HbA1c (%) 7.6 (3.6-16.0) 7.5 (4.3-14.3) 7.7 (3.
Serum creatinine
(mol/L)
139 (41-1101) 149 (43-996) 135 (41
Current smokers 18% (204) 16% (53) 19% (15
Peripheral edema 57% (638) 55% (186) 57% (45
Retinopathy 49% (557) 43% (148) 51% (40
Nephropathy 37% (419) 34% (118) 38% (29
CVD 33% (337) 41% (143) 29% (23
CHF 28% (323) 30% (102) 28% (22
IHD 44% (501) 43% (148) 44% (35
Intermittent
claudication
26% (303) 19% (64) 30% (23
Rest pain 52% (585) 35% (118) 59% (46
Toe pressure (mmHg) 32 (0-145) 33 (0-125) 31 (0-
Toe pressure 30
(mm Hg)
49% (557) 48% (164) 51% (41
Toe pressure 45
(mm Hg)
82% (939) 82% (283) 81% (65
Ankle pressure (mm
Hg)
86 (0-235) 89 (0-235) 85 (0-
Ankle pressure 50
(mm Hg)
13% (148) 10% (33) 14% (11
Ankle pressure 80
(mm Hg)
49% (558) 50% (172) 48% (38
Superficial ulcer 24% (276) 28% (96) 22% (17
Deep ulcer 21% (242) 23% (81) 20% (16
Abscess/osteitis 16% (181) 15% (52) 16% (13
Minor gangrene 33% (376) 27% (92) 35% (28
Major gangrene 6% (71) 7% (24) 6% (47
Ulcer of big toe 21% (247) 23% (80) 21% (16
Ulcer of other toes 24% (281) 23% (81) 25% (19
Fore/midfoot plantar
ulcer
7% (82) 10% (33) 6% (49
Heel ulcer 14% (159) 19% (66) 12% (97
Dorsal surface ulcer 6% (70) 6% (19) 6% (47
Multiple ulcers 27% (312) 19% (66) 31% (24
CHF, Congestive heart failure; CVD, cerebrovascular disease; IHD, ischem
Data are % (n) or median (range), P 1  angiography vs no angiography
reconstructive surgery, P 3  PTA vs reconstructive surgery.
aP  .05.
bP  .01.
cP  .001.after angiography. There were various reasons why an- eiography was not performed (Supplementary Table I)
f which lack of mobility and presence of extensive
omorbidity were the most common. In 14% of cases,
atients did not give consent for either an angiography
r an angioplasty.
After an angiography, 72 of 801 patients (9%) had 99
omplications: renal impairment (n  56), hemorrhage
n  26), vascular occlusion (n  1), and other various
omplications (n  16).
Percutaneous angioplasty. In 314 patients, a PTA
as performed with an average of 1.5 procedures per
y
P1
Medical
treatment
(n  297)
PTA
(n  314)
Reconstructive
surgery
(n  190) P2/P3
75 (44-90) 74 (44-90) 72 (46-92)
63% (186) 63% (117) 58% (111)
15 (0-48) 16 (1-56) 15 (1-54)
b 67% (200) 73% (229) 73% (138)
0) 7.6 (3.6-15.1) 7.6 (4.3-16.0) 7.9 (4.3-12.4)
1) 137 (46-755) 137 (43-883) 123 (41-1101)
15% (45) 17% (53) 28% (52) P2a
56% (166) 58% (177) 58% (110)
49% (144) 53% (165) 50% (94)
35% (104) 41% (129) 34% (65)
c 30% (89) 29% (90) 29% (54)
28% (83) 28% (88) 26% (50)
47% (138) 42% (131) 43% (82)
c 22% (66) 32% (101) 38% (72) P2b
c 49% (145) 63% (195) 67% (126) P2c
32 (0-90) 32 (0-145) 29 (0-90)
50% (148) 51% (159) 55% (104)
81% (240) 81% (255) 82% (156)
90 (20-230) 87 (10-215) 74 (0-160)
10% (31) 14% (43) 22% (41)
43% (127) 46% (145) 61% (116)
22% (66) 21% (67) 25% (47)
19% (56) 21% (67) 20% (38)
18% (52) 18% (57) 11% (20) P3c
b 33% (98) 36% (113) 38% (73) P2c
8% (25) 3% (10) 6% (12)
21% (62) 21% (67) 19% (37)
28% (84) 24% (74) 21% (40)
7% (21) 6% (20) 5% (9)
a 11% (34) 11% (34) 15% (29)
6% (18) 6% (18) 5% (9)
c 26% (78) 32% (101) 35% (66) P2a
rt disease.
 medical treatment vs percutaneous transluminal angioplasty (PTA) graph
801)
-92)
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9)
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Volume 53, Number 6 Apelqvist et al 1585(10%), femoral artery (53%), popliteal artery (35%), and at
the crural arteries in 46% of cases.
Interventions were at a single level in 54% of cases, at
two levels in 35%, at three levels in 10.5%, and at four levels
in 0.5%. After angiography with PTA, 64 complications in
51 patients (16%) were reported; hemorrhage (n  30),
arterial reocclusion (n  10 of whom 5 patients needed
surgery), and miscellaneous (n  24). Three patients died
within 30 days after intervention.
Reconstructive vascular surgery. Reconstructive vas-
cular surgery was performed in 190 cases of which 51%
were distal procedures – tibiotruncal or below (Supple-
mentary Table II). After reconstructive surgery, 41 gen-
eral complications were reported within 30 days in 30
patients (16%): cardiovascular (n  16), cerebrovascular
(n  6), pneumonia (n  3), and miscellaneous (n 
16). Four patients died within 30 days after intervention.
Local complications (n  47) after surgery were seen in
36 cases (19%); hemorrhage (n  13), arterial occlusion
(n  20 of whom 10 needed a reoperation), and infec-
tion (n  14).
No vascular intervention after angiography. In 297
patients, invasive vascular intervention was not performed
after angiography. The reasons are included in Supplemen-
tary Table III. In 33% of these cases, the intervention was
not feasible according to angiography. These patients con-
tinued treatment with the foot care team according to the
program.
Vascular intervention and outcome. To evaluate the
outcome, patients were divided into four groups: those
who had no angiography (n  345), those treated with
PTA (n  314), those treated with reconstructive vascular
surgery (n  190), and those who received medical treat-
Fig. Flow chart of study population with regard to ang
vascular reconstructive surgery performance. *Of all casement only after angiography (n  297). Forty-six patients oere lost to follow-up after angiography and 34 had not
eached the end point (healing with or without amputation
r death).
In total, 36% of patients healed primarily, 16% healed
fter minor amputation, 13% healed after a major amputa-
ion, and 27% died unhealed. Median time to healing was
7 weeks (1-292 weeks). Among patients with nonmeasur-
ble peripheral ankle pressure (n  110), primary healing
as seen in 36 patients (32.7%), minor amputation in 15
atients (13.6%), major amputation in 13 patients (11.8%),
4 patients (40%) died unhealed, and 2 patients dropped
ut (1.8%). At the end of the study, there was a dropout
ate of 5%, and 3% of patients were still in treatment
unhealed). Out of the surviving patients, 72% healed with-
ut a major amputation (Table II).
Factors related to outcome. A multiple regression
nalysis was performed, including factors of demographic
ata, clinical characteristics, comorbidity, and local charac-
eristics (Table I) to identify factors related to primary
ealing (Table III). PTA and vascular surgery increased the
robability for primary healing with an odds ratio (OR) of
.77 and 2.05, respectively. Severity of PVD, age, comor-
idity (congestive heart disease and/or renal impairment),
nd extent of tissue destruction at inclusion were also
elated to probability of healing.
ISCUSSION
In this large prospective study of individuals with dia-
etes, foot ulcers, and severe PVD treated at a multidisci-
linary foot center, the healing rate without major ampu-
ation in surviving patients was 72%. Probability for healing
ithout major amputation was strongly related to severity
hy, percutaneous transluminal angioplasty (PTA), and
after angiography.iograpf PVD, comorbidity, and extent of tissue destruction.
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increase the probability of healing.
During the study period, the foot center received ap-
proximately 3000 new patients with diabetes with a foot
ulcer. At the time of the design of the study, 30% of the
patients with a foot ulcer had severe PVD according to the
criteria for the present study. At present, the corresponding
figure is 49%.
In recent cohort studies, approximately 50% of diabetic
foot ulcers are of ischemic or neuroischemic origin.4,15,16
However, the main focus of diabetic foot treatment is
usually on neuropathy and its consequences.17 There are
substantial numbers of suggested classification systems for
the diabetic foot ulceration, but none of them completely
covers the need for classification and prediction of outcome
that can be used both in clinical practice as well as re-
search.18
Assessment of the need for vascular intervention (re-
constructive vascular surgery or angioplasty) in patients
with ischemic or neuroischemic diabetic foot ulcers has
frequently been based on the presence of progressive clau-
dication, rest pain, or the extent of tissue loss (using the
Fontaine classification). However, pain at rest and claudi-
cation in individuals with diabetic foot ulcers are substan-
tially less frequent than in individuals with ischemia without
diabetes.19
In the absence of symptoms, these patients may present
late, and as a result, vascular intervention is often consid-
ered too late in the progress of a diabetic foot lesion. It is
Table II. Outcome in relation to intervention (n  1146)
No angiography
(n  345)
n %
Primary healing (n  415) 127 37
Minor amputation (n  184) 36 10
Major amputation (n  143) 33 10
Deceased (n  310) 128 37
Dropouts (n  60) 14 4
Still under treatment (n  34) 7 2
Table III. Factors related to ulcer primary healing
OR (95% CI) P value
Age 75 years 1.03 (1.02-1.05) .001
Serum creatinine 130 mol/L 1.59 (1.15-2.2) .005
Ankle pressure 50 mm Hg 1.62 (1.18-2.23) .003
No congestive heart failure 1.81 (1.26-2.95) .01
Single ulcer vs multiple ulcers 2.75 (1.93-3.92) .001
Ulcer of Wagner grades I–II 2.86 (2.06-3.94) .001
PTA 1.77 (1.24-2.53) .02
Reconstructive vascular surgery 2.05 (1.33-3.16) .001
CI, Confidence interval; OR, odds ratio; PTA, percutaneous transluminal
angioplasty.reported that 30% to 50% of individuals with diabetes and aoot ulcers already have gangrene (a score of 4-5 on the
agner scoring system) when the question of revascular-
zation is raised, and these patients are, therefore, consid-
red unsuitable for this intervention.20
The perspective of the present study was to intervene in
n earlier phase to achieve ulcer healing, and thereby reduce
he risk of amputation. To address the problem of late
resentation, noninvasive vascular testing, such as toe pres-
ure and ankle pressure, has been suggested as a screening
or the need of earlier vascular intervention because the
ndings in such testing has been shown to be related to the
utcome of diabetic foot ulcers.7,9 The level of ankle and
oe pressure as inclusion criteria, in the presence of an ulcer,
n our study, were defined according to previous studies of
iabetic foot ulcers as they relate to the risk of amputa-
ion.1,9
In our study, the healing rate without major amputa-
ion was 72% among survivors. In 13% of patients, a major
mputation could not be avoided. Comparisons between
tudies are difficult due to differences in design, setting,
atient selection, definitions, follow-up time, and other
onfounding factors. In the limited number of studies,
ncluding patients with diabetes with ischemic or neurois-
hemic ulcers, the focus is on limb salvage after a specific
ntervention and they often include patients with and with-
ut diabetes, and with and without ulcers.21-23 However,
ur results with regard to healing are similar to other
ublished results,5,24 where healing rates were 70% to 73%.
he present study was not designed to assess limb salvage
ut rate of ulcer healing in all consecutively presenting
atients with diabetes and an ischemic or neuroischemic
lcer. Higher healing rates have been reported in other
tudies in diabetic populations with both neuropathic and
euroischemic ulcers.4,15,25
In the present study, 56% of patients had no angiog-
aphy or invasive vascular intervention (30% and 26%,
espectively), most commonly due to comorbidity, poor
eneral condition, and short life expectancy. Feasibility
or angioplasty or reconstructive vascular surgery accord-
ng to angiography was the limiting factor in 33% of cases
fter angiography. Although lack of walking capacity is
ot per se a contraindication for angiography, it was used
Medical
reatment
n  297) PTA (n  314)
Vascular
surgery
(n  190)
% n % n %
32 121 39 71 37
14 60 19 45 24
15 34 11 31 16
28 63 20 35 18
7 21 7 4 2
3 15 4 4 2t
(
n
96
43
45
84
21s such due to our policy not to consider vascular inter-
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Volume 53, Number 6 Apelqvist et al 1587vention if the patient had permanently lost the use of his
limbs.
When compared to other studies, it has to be recog-
nized that the present study was stopped with regard to
recruitment when magnetic resonance angiography, com-
puted tomography angiography, and subintimal angio-
plasty (recanalization) became routine procedures. Com-
parison with other studies is further hampered by the fact
that most studies report outcome after a specific interven-
tion.20,21,26 The present study indicates that the window of
opportunity for vascular intervention to achieve healing is
strongly related to comorbidity and extent of tissue in-
volvement at the time of intervention.
PTA, frequently multi-segmental (46%) and to the
crural arteries (46%), was done in 27% of patients and
reconstructive vascular surgery in 17%. In most cases, com-
plications were related to comorbidity rather than the vas-
cular intervention per se. This was in agreement with other
studies.6,20 However, we cannot compare the outcome of
PTA vs vascular surgery in the present study, because,
according to the design of the study, vascular surgery was
performed in patients not feasible for PTA. In the extended
follow-up of the bypass versus angioplasty in severe isch-
emia of the leg trial, 452 patients with severe PVD were
followed up for up to 5 years; 42% of the patients were
diabetic.27 In patients who survived for at least 2 years,
vascular surgery was associated with significant increase in
subsequent overall survival. Furthermore, PTA had a
higher early failure rate.28
An observation from the present study is that only a
limited number of patients could be eligible for a random-
ized controlled trial comparing PTA with vascular surgery
due to patients’ comorbidity and the requirement of feasi-
bility for both interventions in such a study.
In the present study, a multiple regression analysis
showed a substantially higher probability for primary heal-
ing without major amputation after vascular intervention as
compared to those who did not have such intervention.
However, this finding is still to be confirmed by an inter-
ventional comparative study. Comorbidity (congestive
heart failure and/or renal impairment), severity of PVD
(ankle pressure50 mmHg), and extent of tissue involve-
ment (Wagner grades 3-5 and multiple ulcers) were related
to a low probability for primary healing. Presence of foot
ulcers in individuals with diabetes has to be recognized as a
sign of multiorgan disease. This is confirmed by a substan-
tial number of studies and is further emphasized by the
present findings.5,16,29
Some methodological issues need to be considered
when evaluating the present cohort study. A potential
negative selection bias has to be taken into account, be-
cause the patients were admitted to a university-based foot
center, and no exceptions were made with regard to age,
comorbidity, or expected survival, whereas it cannot be
excluded that a few and possibly many superficial ulcers
were treated in primary health care without the knowledge
of the foot team. Definitions of outcome can be very
complex, an issue that has been previously analyzed.15 Oatients in our study were divided into groups according to
utcome; primary healing, minor amputation, major am-
utation, and death unhealed. In some studies, minor
mputations are included in the group primarily healed.5,24
n many health care systems, there are limited possibilities
or following up patients until healing is achieved. The
wedish system, due to its geographic responsibilities and
eimbursement system, makes it possible to follow up pa-
ients until a specific end point, irrespective of the care
rovider.30 This may explain the present dropout rate of
%. Our patients are comparable with regard to comorbid-
ty and demographic data, but are somewhat older than
atients in other studies regarding vascular interven-
ion.23,24,26
In large cohort studies of patients with diabetes and
oot ulcers, the outcome has been measured with regard to
he possibility of primary healing (healing without ampu-
ation) or of avoiding major amputation at or above the
nkle.15,25 In some studies of patients with diabetes, about
0% to 15% (and sometimes as many as 30%) of patients
ho were considered not suitable for vascular surgery have
een shown to heal without any amputation or without a
ajor amputation, which is confirmed by the present find-
ngs.1,13,25 As mentioned previously, studies with regard to
ascular intervention, on the other hand, have focused on
limb salvage” and graft survival,23,24,31 indicating a need
o recognize and introduce decreased perfusion or impaired
irculation as an indication for intervention in the diabetic
oot to achieve and maintain healing and to avoid or delay
future amputation.4,25,32,33
In conclusion, comorbidity, severity of PVD, and
xtent of tissue involvement were the most important
actors that negatively affected the probability of healing.
urthermore, the present study indicates the value of
evascularization in patients with diabetes with neurois-
hemic or ischemic ulcers to achieve healing. A higher
rimary healing rate was seen in those who had vascular
ntervention.
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Definitions. An ulcer was defined as a skin lesion with
or without necrosis penetrating the full thickness of the
dermis. Gangrene was defined as a continuous necrosis of
the skin and underlying structures (muscle or bone) indi-
cating irreversible damage that would be unlikely to heal
without loss of some part of the extremity (Wagner grades
4-5).1 Major gangrene (Wagner grade 5) was defined as a
gangrene involving most of the foot.
Cardiovascular diseases. Hypertension, angina pec-
toris, myocardial infarction, congestive heart failure, non-
ischemic heart disease, and cerebrovascular disease were
defined as previously described.2 Diabetic retinopathy was
recorded after retinal photography by an ophthalmologist.
Diabetic nephropathy was considered present at persistent
urine albumin 300 mg/L.2
Outcomes were classified as (1) primary healing, de-
fined as healing without any amputation with intact skin for
6 months or intact skin at the time of death; (2) minor
amputation, defined as amputation of one or more toes or
some part of the foot at or below the ankle; (3) major
amputation, defined as amputation above the ankle3; and
(4) death unhealed, defined as death without healing with
or without any amputation.
Sensory/motor neuropathy was defined as vibratory
pressure threshold values 25V. Peripheral edema was
considered present when swelling of the foot was so pro-
nounced as to leave imprint after pressure by a finger. Deep
foot infection (Wagner grade 3) included osteomyelitis/
osteitis, deep foot abscess, and purulent soft tissue infec-
tion. All patients considered to have osteomyelitis had an
open lesion fulfilling at least three of the following crite-
rion: cellulitis, positive bacterial culture, radiological
and/or scintigraphic evidence, and pathologic anatomic
diagnosis.4
Rest pain was defined as severe persistent pain localized
to the foot and relieved by lowering of the foot. Claudica-
tion was defined as recurrent cramping pain or tightness in
the calf induced by exercise and relieved by rest.5 Neurois-
chemic/ischemic ulcers were considered present at ankle
pressure 80 mm Hg or toe pressure 45 mm Hg or at
Wagner grades 4 to 5 if distal pressure was not obtained.6
MANAGEMENT/TREATMENT
The patients were treated as outpatients, but in case of
deep infection associated with septic condition, foot sur-
gery, amputations, vascular surgery, or exacerbation of
intercurrent disease, they were treated as inpatients under
the supervision of the foot team.
Patients were offered medical treatment to improve
metabolic control and optimize treatment of comorbidity.7
When needed, patients were also given supplementary nu-
trition and rehydration treatment.8 When clinical signs of
infection were present, oral treatment with antibiotics was
provided, often according to ulcer microbiological culture
or combining cephalosporin, quinolone, or metronidazole
2ith dicloxacillin or clindamycin. Patients with deep ab-
cess or acute osteomyelitis were hospitalized and intrave-
ous antibiotics were used.9 A differentiated program for
nalgesia was used related to cause and intensity of pain.
URGICAL TREATMENT
Surgery was performed when deemed necessary by an
rthopedic surgeon. Local surgical debridement of the
esions was performedwhen required.Whenever absence of
nfection and pain so allowed, dry necrosis was left to
ummify. Incision and drainage were mandatory in case of
deep plantar abscess, and resection was performed in cases
f osteitis/osteomyelitis not responding to antibiotic treat-
ent.
Amputation was performed at the discretion of the
rthopedic surgeon according to a preset protocol were
ndications were progressive gangrene, septic condition,
nd rest pain not responding to conservative treatment. A
onhealing ulcer was not considered as an indication for
mputation. The level of amputation was chosen on clinical
rounds as the most distal level possible where healing
ould be anticipated, the minimal requirement being intact
kin with no signs of local infection or severe ischemia. The
owest level used for amputation was at the metatarsopha-
angeal level. All indications for amputation were recorded
ccording to protocol. Resection of less than the distal
halanx was not considered an amputation.
FF-LOADING
All patients were offered off-loading equipment ad-
usted to their individual needs. Protective or therapeutic
hoes for indoor and outdoor use and individually fitted
nsoles were used in the majority of patients. In cases of
lantar or heel ulcers, total contact casting was used when
ppropriate. Specially made orthotic appliances (orthoses)
ere used in cases of severe midfoot or ankle deformities.
ff-loading by crutches or wheel chair was occasionally
sed.
OPICAL TREATMENT
According to the individual wound bed condition,
ifferent topical treatments were prescribed in written form
y the multidisciplinary team. Dressing changes were per-
ormed under supervision of a registered nurse in primary
ealth care or home nursing services. The team maintained
aytime telephone service for support 5 days a week. Most
ommonly used dressings were foam dressings, hydro-
ber, hydrogels, silicon net, or hydrophobic gauze. Silver
nd Cadexomere iodine were used as topical antimicrobial
gents when appropriate. External compression bandages
r intermittent compression therapies were used in the
resence of peripheral edema.7
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aupplementary Table I. Reasons why angiography was
ot performed (n  345)
n %
ustained lack of walking capacity 74 21
edical condition not allowing angiography 68 20
igns of ulcer healing before angiography 47 13
nformed consent not given 44 13
eceased 16 5
ajor amputation performed before angiography 17 5
ther confounding reasons 41 12
rop out 14 4
nknown reasons 24 7
n cases where more than one reason was recognized, only the mostupplementary Table II. Levels of vascular
econstructions performed
ascular reconstruction n  190 %
ortobifemoral 8 4
emorofemoral cross-over 3 1
emoropopliteala 36 20
emoro-truncal 5 3
emoro-ant. tibial 42 24
emoro-post. tibial 14 9
emoro-fibular 13 5
emoro-pedal 30 13
EA common femoral 25 9
xploration 20 12
n 6 cases (1 with an aortobifemoral reconstruction and 5 with TEA) an
dditional distal procedure was performed.upplementary Table III. Reasons for not performing
urgical or endovascular treatment after angiography (n 
97)
N %
ot feasible according to angiography 99 33
ein graft not presenta 33 11
oor general condition 50 17
onsent not given 29 10
ealed ulcer 21 7
ocation of ulcersa 17 6
ajor amputation 4 1
eceased 6 2
nknown reasons 38 13In cases where PTA was not feasible.
